Novo Nordisk is gradually ending production of human insulin pens, a spokesperson confirmed to Reuters. Instead, the company is channeling investments into manufacturing its popular obesity and ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp up manufacturing of its popular obesity and diabetes injections. The ...

Dr Vincent Simpson aims to reduce plastic waste and save the NHS money by championing reusable insulin pens [BBC] A doctor and honorary researcher at the University of Exeter is leading a campaign ...

A doctor and honorary researcher at the University of Exeter is leading a campaign to make reusable insulin pens the standard for treating diabetes patients. Dr Vincent Simpson aims to cut down on ...

The introduction of smart insulin pens, which represent a substantial development in the technology currently used to control diabetes, may benefit patients who are reliant on insulin by enhancing ...

"What students can read in schools provides the foundation for their lives," says PEN America Eric Charbonneau/Getty; Lou Rocco/ABC via Getty; VALERIE MACON/AFP via Getty Book bans are sharply on ...

Novo said last year it would pull its Levemir insulin from the U.S. market at the end of 2024, months after cutting its price by 65% to $108 a vial and $162 for a 5-pack of injector pens.

Novo said last year it would pull its Levemir insulin from the U.S. market at the end of 2024, months after cutting its price by 65% to $108 a vial and $162 for a 5-pack of injector pens.